[1]
Sheela M, P. , S, P., Kishor P B, K. and Murthy, D.K. 2022. In silico Evaluation of 2,4-diaminoquinazoline Derivatives as Possible Anticancer agents. Current Trends in Biotechnology and Pharmacy. 16, 1 (Feb. 2022), 14–22. DOI:https://doi.org/10.5530/ctbp.2022.1.2.